Day: August 17, 2021

Irvine, CA, Aug. 17, 2021 (GLOBE NEWSWIRE) — FDCTech, Inc. (“FDC” or the “Company,” OTCQB: FDCT), a fully integrated financial technology company with a full suite of digital financial services solutions, today announced the launch of Condor Price Hub, new connectivity as a service platform that enhances market trading liquidity and execution. This platform offers retail forex brokers, hedge funds, and emerging market banks (‘takers’) the opportunity to connect to institutional multi-asset market data and trade execution (‘liquidity’) access across multiple trading venues provided by liquidity providers, banks, and other hubs (“makers”). The Condor Price Hub is flexible and integrates seamlessly with dealing desk solutions. It reduces the time to market for connecting...

PHILADELPHIA and PORTERVILLE, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL), delivering the infrastructure of change, announced today it was awarded a contract by the Tule River Tribe Gaming Authority to provide owner’s representative services for Phase 1 of the relocation of the Authority’s Eagle Mountain Casino. Valued at $200 million, the project will “relocate” casino operations to a new site approximately 17 miles from the current location. The first phase of the work includes building a new 2,000-seat Event Center, River Steak House, coffee house, 24-hour diner, sports bar and grill, and gaming spaces for 1,750 slot machines and 20 table games. Hill’s services will encompass construction management, scheduling, estimating and cost management, quality control, planning and coordination with third-party...

Invitation to Q2 2021 Presentation 24 August BW Offshore will release its Half-Year 2021 results on Tuesday 24 August at 07:30 CEST. A conference call followed by Q&A will be hosted by CEO Marco Beenen and CFO Ståle Andreassen the same day at 09:00 CEST. Conference call information: To dial in to the conference call where the quarterly results and Q&A will be hosted, please dial in to one of the following numbers: Norway: +47 2396 3938UK: +44 3333 009 260US: +1 6467 224 957France: +33 170 750 737Singapore: +65 6429 8349 (PIN: 81560184#) You can also follow the presentation via webcast with supporting slides, available on:   https://streams.eventcdn.net/bwo/q2-2021/register Please note that if you follow the webcast via the above URL, you will experience a 30 second delay compared to the main conference call. The web page works...

Jyske Bank anticipates releasing the following financial statements in 2022:Announcement of the 2021 results 22 FebruaryAnnual report 2021 22 FebruaryRisk Management Report 2021 22 FebruaryInterim report for the first quarter of 2022 3 MayInterim report for the first half of 2022 16 AugustInterim report for the first nine months of 2022 1 NovemberJyske Bank’s Annual General Meeting will be held on Tuesday, 22 March 2022. Items to be included on the agenda must be submitted in writing to the Jyske Bank management by 7 February 2022. Yours faithfully, Jyske Bank Contact person: Birger Krøgh Nielsen, CFO, +45 89 89 64 44AttachmentJyske Bank Financial Calendar 2022

Business email compromise (BEC) and ransomware attacks prove most costly phishing threats to large businesses SUNNYVALE, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) — Proofpoint, Inc. (NASDAQ: PFPT), a leading cybersecurity and compliance company, and Ponemon Institute, a top IT security research organization, today released the results of a new study on the Cost of Phishing. The report reveals that the cost of phishing attacks have almost quadrupled over the past six years, with large U.S. companies losing an average of $14.8 million annually (or $1,500 per employee), up sharply from 2015’s figure of $3.8 million.  According to the study, which surveyed nearly 600 IT and IT security practitioners, the most expensive threats to businesses include BEC and ransomware attacks. But the costs to organizations extend far beyond the funds...

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) — Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the second quarter ended June 30, 2021. Recent HighlightsClosed a $13.2 million public offering Up listed to the Nasdaq Capital Market Hosted a key opinion leader (KOL) webinar focused on PT00114 for the regulation of stress in patients with Depression, PTSD, Anxiety and Addiction Received FDA comment to provide clinical sites with ready-to-inject clinical vials of PT00114; to result in IND refiling in the fourth quarter“During the second quarter and year to date, we made important progress towards advancing PT00114 into the clinic, in order to treat stress-related neuropsychiatric disorders which afflict...